Warfarin vs. Asprin in Reduced Ejection Fraction

More documents

Recommendations

Info

Major Hemorrhage (Frequencies* : Rate /yr) Warfarin Aspirin Rate P Ratio Overall 72 (1.78%) 35 (0.87%) 2.05
Conclusions • No overall difference for Primary Outcome • Suggestive benefit of warfarin for Primary Outcome at 4 years and beyond • Warfarin reduces ischemic stroke risk throughout follow-up • More major hemorrhage with warfarin, but intracerebral and intracranial hemorrhage similar • No difference for the Main Secondary Outcome (Primary Outcome + MI and HFH)
Page 1 and 2: WARFARIN vs. ASPIRIN in REDUCED CAR
Page 3 and 4: Background • Heart failure patien
Page 5 and 6: Key Inclusion Criteria 1. Normal si
Page 7 and 8: Statistical Design • Primary null
Page 9 and 10: Randomized, n Lost to Follow-up, n
Page 11 and 12: Baseline Medication Time in Therape
Page 13 and 14: Warfarin vs. Aspirin Hazard Ratios
Page 15: No. at risk Main Secondary Outcome
Page 19 and 20: STUDY ORGANIZATION Sponsor - the Na

Warfarin vs. Asprin in Reduced Ejection Fraction

Create successful ePaper yourself

Delete template?

Save as template?